Project Grant R21DE034848
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$428K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), is focused on regeneration of alveolar bone tissue. The $476,287 award aims to investigate the role of the MERTK receptor tyrosine kinase in regulating early bone formation and its potential as a therapeutic target for alveolar bone regeneration. Specific objectives include determining the effects of MERTK...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $600,029 to Cedars-Sinai Medical Center to conduct research on the mechanisms of hyperactive RAS signaling in craniofacial and dental diseases. The project aims to elucidate how RAS/MAPK dysregulation disrupts cranial bone and dental formation, with the goal of improving early diagnosis and therapeutic...
This federal Project Grant award of $248,999 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research on the role of CD4+ memory T cell subtypes in periodontal disease recurrence. The primary objectives are to: 1) identify the spatiotemporal development of CD4+ memory T cells in periodontal tissues, 2) elucidate the pathogenicity of periodontal disease-induced CD4+ memory T cell subtypes,...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), provides $645,009 to the Augusta University Research Institute, Inc. to investigate the role of osteocyte NOD1 signaling in bone loss associated with periodontal disease. The key objectives are to: 1) determine if osteocytes use the NOD1 receptor to recognize periodontal pathogens and induce the bone resorption...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, provides $1,849,232.90 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to identify the cellular and molecular identity of genes and pathways defining dental mesenchymal cell differentiation and fate early in tooth development. The goal is to harness this information to develop potential...
This federal Project Grant award of $424,560 from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will support research to investigate the effects of the natural compound hesperidin on bone regeneration and bone morphogenetic protein (BMP) function. The University of North Carolina at Chapel Hill will utilize an innovative 3D co-culture platform to simulate the bone microenvironment and understand...
This federal Project Grant award of $429,000.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to determine the functional roles and mechanisms of the human microbiome and metabolome in the pathogenesis of oral squamous cell carcinoma (OSCC), a prevalent and lethal form of head and neck cancer. The research aims to 1) define OSCC-associated metagenomic and...
This $1,820,748 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research program (CFDA 93.121), aims to disrupt implicit bias in dental clinical decision-making and mitigate its effect on the dentist-scientist workforce pathway. The award to the University of Maryland, Baltimore (UMB) has two key objectives: (1) assessing the multi-level impact of implicit bias on oral healthcare, including clinician...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $513,574 to the Regents of the University of Michigan to study the mechanisms that lead to osteonecrosis of the jaw (ONJ) in patients taking anti-resorptive medications. The researchers aim to elucidate the cellular and genetic factors that contribute to ONJ, and develop a polygenic risk score to predict susceptibility to...